anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 218,401-218,430
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

218,401-218,430 of 303,780

filter-aware
14
The slide highlights low-grade adverse events to support a claim of a favorable safety profile.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
15
The slide highlights exceptional progression-free survival in a high-need patient population.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
16
The slide defines DCR and provides a comparative analysis against standard of care (SOC) in third-line therapy.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
17
The chart uses a swimmer plot format to visualize patient status (on treatment vs follow-up) and survival duration.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
18
The chart shows tumor volume over time, highlighting the superior performance of the THIO + Atezo combination compared to monotherapies and control.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
19
The table compares clinical trial metrics for THIO-101 targets versus existing chemotherapy SoC.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
20
The slide shows a confocal microscopy image alongside a dot plot quantifying TIFs over time (0, 24, 48, 72 hours).MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
21
The slide outlines a clinical trial design using a basket/umbrella approach to test THIO in combination with various anti-PD-1/PD-L1 therapies.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
22
The slide uses two line charts to demonstrate tumor volume reduction and the effect of rechallenge.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
23
The table compares clinical endpoints (Toxicity, ORR, PFS, OS) for the current standard of care (LONSURF) against the trial's goals.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
24
The slide shows tumor volume reduction over time in two different cancer models (SCLC and HCC) comparing control groups against various THIO-based combination treatments.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
25
The chart shows tumor volume over time (days) with error bars, highlighting the efficacy of THIO.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
26
Shows two distinct experiments: initial tumor growth inhibition and subsequent rechallenge immunity.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
27
The slide outlines a clinical development pathway involving immune activation and combination therapies.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
29
Includes a logo grid at the bottom representing past company affiliations.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Team1 hit
30
Includes footnotes regarding option ownership and cash proceeds, plus a note on insider ownership percentage.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Team1 hit
31
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
32
The chart compares the massive combined market of major CPIs ($42B) against a smaller reference point ($0.5B).MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Market Size1 hit
33
The slide highlights a recent acquisition event as a benchmark for valuation.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Market Size1 hit
34
The slide uses a timeline format with star icons to denote major inflection points.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
35
The slide serves as social proof and a milestone marker for the company's public listing.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
01
Slide 1
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Attention1 hit
02
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
03
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
04
The slide presents a side-by-side comparison of income statement performance and a specific balance sheet snapshot.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Loop · Logic Chain1 hit
05
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
01
Slide 1
Moelis & Company | Investor Presentation Deck | 24 slidesMoelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations 1 hit
02
Moelis & Company | Investor Presentation Deck | 24 slidesMoelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations 1 hit
03
The slide uses a structured list format to present key organizational strengths.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
The slide uses a three-column layout to categorize key performance indicators.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit